Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing

Wound Repair and Regeneration

Volumn 20, Issue 1, 2012, Pages 15-27

  Balaji, Swathi ^a,b   Vaikunth, Sachin S ^b   Lang, Stephanie A ^b   Sheikh, Abdul Q ^a   Lim, Foong Y ^b   Crombleholme, Timothy M ^b   Narmoneva, Daria A ^a,b  

^a University of Cincinnati   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; INTERLEUKIN 6; NANOFIBER; PHOSPHATE BUFFERED SALINE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; CELL INFILTRATION; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; FEMALE; INFLAMMATION; MICROENVIRONMENT; MORPHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN INJURY; SKIN ULCER; TISSUE ENGINEERING; WOUND CLOSURE; WOUND DEHISCENCE; WOUND HEALING;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; MICE; NANOFIBERS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOLYSIS; SKIN ULCER; TISSUE ENGINEERING; WOUND HEALING;

EID: 84856350788     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00750.x     Document Type: Article

References (45)

1. Akopian G, Nunnery SP, Piangenti J, Rankin P, Rinoie C, Lee E, Alexander M,. Outcomes of conventional wound treatment in a comprehensive wound center. Am Surg 2006; 72: 314-317.
2. Falanga V,. Wound healing and its impairment in the diabetic foot. Lancet 2005; 366: 1736-1743. (Pubitemid 41587454)
3. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H,. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016. (Pubitemid 34762196)
4. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, Murphy G, Schultz G,. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Rep Regen 1999; 7: 442-452. (Pubitemid 30027566)
5. Brem H, Tomic-Canic M,. Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219-1222. (Pubitemid 46718408)
6. Liu ZJ, Velazquez OC,. Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing. Antioxid Redox Signal 2008; 10: 1869-1882.
7. Blakytny R, Jude E,. The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med 2006; 23: 594-608. (Pubitemid 43830059)
8. Jude EB, Blakytny R, Bulmer J, Boulton AJ, Ferguson MW,. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers. Diabet Med 2002; 19: 440-447. (Pubitemid 34639153)
9. Cianfarani F, Zambruno G, Brogelli L, Sera F, Lacal PM, Pesce M, Capogrossi MC, Failla CM, Napolitano M, Odorisio T,. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol 2006; 169: 1167-1182. (Pubitemid 351194354)
10. Pradhan L, Nabzdyk C, Andersen ND, LoGerfo FW, Veves A,. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med 2009; 11: e2: 1-24.
11. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, Nedeau A, Thom SR, Velazquez OC,. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007; 117: 1249-1259. (Pubitemid 46718413)
12. Keswani SG, Katz AB, Lim FY, Zoltick P, Radu A, Alaee D, Herlyn M, Crombleholme TM,. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Rep Regen 2004; 12: 497-504. (Pubitemid 39314331)
13. Michaels J 5th, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, Gurtner GC,. db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Rep Regen 2007; 15: 665-670. (Pubitemid 47493885)
14. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC,. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002; 106: 2781-2786. (Pubitemid 35396976)
15. Loomans CJ, de, Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de, Boer HC, Verhaar MC, Braam B, Rabelink TJ, van, Zonneveld AJ,. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195-199. (Pubitemid 38044715)
16. Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D, Kamm RD, Zhang S, Lee RT,. Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 2005; 111: 442-450. (Pubitemid 40204428)
17. Narmoneva DA, Oni O, Sieminski AL, Zhang S, Gertler JP, Kamm RD, Lee RT,. Self-assembling short oligopeptides and the promotion of angiogenesis. Biomaterials 2005; 26: 4837-4846. (Pubitemid 40343031)
18. Caravaggi C, De Giglio R, Pritelli C, Sommaria M, Dalla Noce S, Faglia E, Mantero M, Clerici G, Fratino P, Dalla Paola L, Mariani G, Mingardi R, Morabito A,. HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial. Diabetes Care 2003; 26: 2853-2859. (Pubitemid 37205558)
19. Voinchet V, Vasseur P, Kern J,. Efficacy and safety of hyaluronic acid in the management of acute wounds. Am J Clin Dermatol 2006; 7: 353-357. (Pubitemid 46998569)
20. Gordon A, Kozin ED, Keswani SG, Vaikunth SS, Katz AB, Zoltick PW, Favata M, Radu AP, Soslowsky LJ, Herlyn M, Crombleholme TM,. Permissive environment in postnatal wounds induced by adenoviral-mediated overexpression of the anti-inflammatory cytokine interleukin-10 prevents scar formation. Wound Rep Regen 2008; 16: 70-79.
21. Javazon EH, Keswani SG, Badillo AT, Crombleholme TM, Zoltick PW, Radu AP, Kozin ED, Beggs K, Malik AA, Flake AW,. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Rep Regen 2007; 15: 350-359. (Pubitemid 46817411)
22. Hurley JR, Balaji S, Narmoneva DA,. Complex temporal regulation of capillary morphogenesis by fibroblasts. Am J Physiol Cell Physiol 2010; 299: C444-453.
23. Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, Zhang F, He J, Fan D, Langley R, Fidler IJ,. Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am J Pathol 2009; 174: 1972-1980.
24. Rosa JS, Flores RL, Oliver SR, Pontello AM, Zaldivar FP, Galassetti PR,. Sustained IL-1alpha, IL-4, and IL-6 elevations following correction of hyperglycemia in children with type 1 diabetes mellitus. Pediatr Diabetes 2008; 9: 9-16.
25. Davis ME, Hsieh PC, Takahashi T, Song Q, Zhang S, Kamm RD, Grodzinsky AJ, Anversa P, Lee RT,. Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A 2006; 103: 8155-8160. (Pubitemid 43801068)
26. Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, Holmes JW, Longaker MT, Yee H, Gurtner GC,. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 2007; 21: 3250-3261. (Pubitemid 47565543)
27. Sheridan RL, Tompkins RG,. What's new in burns and metabolism. J Am Coll Surg 2004; 198: 243-263. (Pubitemid 38175242)
28. Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H,. The role of vascular endothelial growth factor in wound healing. J Surg Res 2009; 153: 347-358.
29. Nagato H, Umebayashi Y, Wako M, Tabata Y, Manabe M,. Collagen-poly glycolic acid hybrid matrix with basic fibroblast growth factor accelerated angiogenesis and granulation tissue formation in diabetic mice. J Dermatol 2006; 33: 670-675. (Pubitemid 44536371)
30. Badillo AT, Redden RA, Zhang L, Doolin EJ, Liechty KW,. Treatment of diabetic wounds with fetal murine mesenchymal stromal cells enhances wound closure. Cell Tissue Res 2007; 329: 301-311. (Pubitemid 47020518)
31. Badillo AT, Chung S, Zhang L, Zoltick P, Liechty KW,. Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J Surg Res 2007; 143: 35-42. (Pubitemid 47562443)
32. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M, Squadrito F,. Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003; 46: 546-555. (Pubitemid 36577800)
33. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC,. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004; 164: 1935-1947. (Pubitemid 38669343)
34. Badiavas EV, Falanga V,. Treatment of chronic wounds with bone marrow-derived cells. Arch Dermatol 2003; 139: 510-516. (Pubitemid 36427615)
35. Dinh TL, Veves A,. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg 2006; 117 (Suppl. 7): 152S-157; discussion 8S-9S. (Pubitemid 44317780)
36. Marston WA,. Dermagraft, a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer. Expert Rev Med Devices 2004; 1: 21-31. (Pubitemid 40220416)
37. Marston WA, Usala A, Hill RS, Mendes R, Minsley MA,. Initial report of the use of an injectable porcine collagen-derived matrix to stimulate healing of diabetic foot wounds in humans. Wound Rep Regen 2005; 13: 243-247. (Pubitemid 40848016)
38. Adair-Kirk TL, Senior RM,. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 2008; 40: 1101-1110.
39. Isner JM, Vale PR, Symes JF, Losordo DW,. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 2001; 89: 389-400. (Pubitemid 34132654)
40. Margolis DJ, Crombleholme T, Herlyn M,. Clinical protocol: phase I trial to evaluate the safety of H5.020CMV.PDGF-B for the treatment of a diabetic insensate foot ulcer. Wound Rep Regen 2000; 8: 480-493. (Pubitemid 32141452)
41. Gelain F, Unsworth LD, Zhang S,. Slow and sustained release of active cytokines from self-assembling peptide scaffolds. J Control Release 2010; 145: 231-239.
42. Sieminski AL, Was AS, Kim G, Gong H, Kamm RD,. The stiffness of three-dimensional ionic self-assembling peptide gels affects the extent of capillary-like network formation. Cell Biochem Biophys 2007; 49: 73-83. (Pubitemid 47574999)
43. Martinez-Ferrer M, Afshar-Sherif AR, Uwamariya C, de, Crombrugghe B, Davidson JM, Bhowmick NA,. Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. Am J Pathol 2010; 176: 98-107.
44. Nguyen PD, Tutela JP, Thanik VD, Knobel D, Allen RJ Jr, Chang CC, Levine JP, Warren SM, Saadeh PB,. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators. Wound Rep Regen 2010; 18: 553-559.
45. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S,. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002; 109: 625-637. (Pubitemid 34628725)